Screener
Eikon Therapeutics, Inc. EIKN Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Eikon Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.
The source filing: Eikon Therapeutics, Inc.’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 4:13 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-216791
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $161,154 | $104,901 |
| Marketable securities, current | 351,028 | 231,074 |
| Prepaid expenses and other current assets | 16,919 | 12,542 |
| Restricted cash | 400 | 400 |
| Total current assets | 529,501 | 348,917 |
| Property and equipment, net | 138,067 | 142,898 |
Item 1. Condensed Financial Statements (Unaudited).
FAQ
- What is Eikon Therapeutics, Inc.'s short-term investments?
- Eikon Therapeutics, Inc. (EIKN) reported short-term investments of $351.03M in Q1 2026.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.
Ask your AI about Eikon Therapeutics, Inc.'s short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude